136 related articles for article (PubMed ID: 1540408)
1. N-acetylcysteine: a new approach to anti-HIV therapy.
Roederer M; Ela SW; Staal FJ; Herzenberg LA; Herzenberg LA
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):209-17. PubMed ID: 1540408
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine: potential for AIDS therapy.
Roederer M; Staal FJ; Ela SW; Herzenberg LA; Herzenberg LA
Pharmacology; 1993; 46(3):121-9. PubMed ID: 8441760
[TBL] [Abstract][Full Text] [Related]
3. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS.
Witschi A; Junker E; Schranz C; Speck RF; Lauterburg BH
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):141-3. PubMed ID: 7734187
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine inhibits latent HIV expression in chronically infected cells.
Roederer M; Raju PA; Staal FJ; Herzenberg LA; Herzenberg LA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):563-7. PubMed ID: 1931232
[TBL] [Abstract][Full Text] [Related]
5. Effects of glutathione precursors on human immunodeficiency virus replication.
Simon G; Moog C; Obert G
Chem Biol Interact; 1994 Jun; 91(2-3):217-24. PubMed ID: 8194136
[TBL] [Abstract][Full Text] [Related]
6. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.
Raju PA; Herzenberg LA; Herzenberg LA; Roederer M
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):961-7. PubMed ID: 7811547
[TBL] [Abstract][Full Text] [Related]
7. NAC: first controlled trial, positive results.
James JS
AIDS Treat News; 1996 Jul; (no 250):1-3. PubMed ID: 11363634
[TBL] [Abstract][Full Text] [Related]
8. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.
Rushworth GF; Megson IL
Pharmacol Ther; 2014 Feb; 141(2):150-9. PubMed ID: 24080471
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine replenishes glutathione in HIV infection.
De Rosa SC; Zaretsky MD; Dubs JG; Roederer M; Anderson M; Green A; Mitra D; Watanabe N; Nakamura H; Tjioe I; Deresinski SC; Moore WA; Ela SW; Parks D; Herzenberg LA; Herzenberg LA
Eur J Clin Invest; 2000 Oct; 30(10):915-29. PubMed ID: 11029607
[TBL] [Abstract][Full Text] [Related]
10. Redox imbalance and its control in HIV infection.
Nakamura H; Masutani H; Yodoi J
Antioxid Redox Signal; 2002 Jun; 4(3):455-64. PubMed ID: 12215212
[TBL] [Abstract][Full Text] [Related]
11. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals.
Staal FJ; Roederer M; Israelski DM; Bubp J; Mole LA; McShane D; Deresinski SC; Ross W; Sussman H; Raju PA
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):305-11. PubMed ID: 1540417
[TBL] [Abstract][Full Text] [Related]
12. TRPM2 channel protective properties of N-acetylcysteine on cytosolic glutathione depletion dependent oxidative stress and Ca2+ influx in rat dorsal root ganglion.
Özgül C; Nazıroğlu M
Physiol Behav; 2012 May; 106(2):122-8. PubMed ID: 22300897
[TBL] [Abstract][Full Text] [Related]
13. Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach.
Santangelo F
Curr Med Chem; 2003 Dec; 10(23):2599-610. PubMed ID: 14529474
[TBL] [Abstract][Full Text] [Related]
14. Glutathione and N-acetylcysteine suppression of human immunodeficiency virus replication in human monocyte/macrophages in vitro.
Ho WZ; Douglas SD
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1249-53. PubMed ID: 1520537
[TBL] [Abstract][Full Text] [Related]
15. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
Prochaska HJ; Rubinson L; Yeh Y; Baron P; Polsky B
Mol Pharmacol; 1994 May; 45(5):916-21. PubMed ID: 8190108
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress.
Grinberg L; Fibach E; Amer J; Atlas D
Free Radic Biol Med; 2005 Jan; 38(1):136-45. PubMed ID: 15589382
[TBL] [Abstract][Full Text] [Related]
17. Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia.
Ushmorov A; Hack V; Dröge W
Cancer Res; 1999 Jul; 59(14):3527-34. PubMed ID: 10416620
[TBL] [Abstract][Full Text] [Related]
18. The role of oxidative imbalance in progression to AIDS: effect of the thiol supplier N-acetylcysteine.
Malorni W; Rivabene R; Lucia BM; Ferrara R; Mazzone AM; Cauda R; Paganelli R
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1589-96. PubMed ID: 9840292
[TBL] [Abstract][Full Text] [Related]
19. Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of
Crinelli R; Zara C; Smietana M; Retini M; Magnani M; Fraternale A
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31181621
[TBL] [Abstract][Full Text] [Related]
20. Silica-induced apoptosis in alveolar macrophages: evidence of in vivo thiol depletion and the activation of mitochondrial pathway.
Hu S; Zhao H; Al-Humadi NH; Yin XJ; Ma JK
J Toxicol Environ Health A; 2006 Jul; 69(13):1261-84. PubMed ID: 16754540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
